295 related articles for article (PubMed ID: 9512688)
1. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
Miura K; Nakao N; Yoshimoto A; Yamano T; Inoue J; Takayasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
[TBL] [Abstract][Full Text] [Related]
2. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
3. [Comparative studies on the antitumor activities and side effects of segmental SMANCS/Lip-TAE with segmental SMANCS/Lip-TAI for hepatocellular carcinoma].
Matoba M; Okimura T; Yamamoto I
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():73-9. PubMed ID: 9512692
[TBL] [Abstract][Full Text] [Related]
4. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
Hirashima N
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
[TBL] [Abstract][Full Text] [Related]
5. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
[TBL] [Abstract][Full Text] [Related]
6. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
Shibata H; Sogabe M; Tsutsui A; Yokoi T; Morimoto M; Fukuda T; Hayashi S; Muguruma N; Ohkita Y; Okahisa T; Okamura S; Ito S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701
[TBL] [Abstract][Full Text] [Related]
7. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
8. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
[TBL] [Abstract][Full Text] [Related]
9. [Arterial infusion of SMANCS for multiple recurrent tumors after hepatic resection].
Takano S; Kono S; Iwai S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():34-8. PubMed ID: 9512685
[TBL] [Abstract][Full Text] [Related]
10. [Outcome of TAE for hepatocellular carcinoma: comparative study of SMANCS-TAE and non-SMANCS/LpTAE].
Itsubo M; Koike K; Toda G
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():84-9. PubMed ID: 9512694
[TBL] [Abstract][Full Text] [Related]
11. [A successful treatment using SMANCS-TAE for hepatocellular carcinoma with tumor thrombus in the portal trunk].
Fukushima M; Fukutomi T; Tanabe Y; Hiroshige K; Yoshida K
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1073-6. PubMed ID: 8687225
[TBL] [Abstract][Full Text] [Related]
12. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
Hasegawa I; Hirashima N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
[TBL] [Abstract][Full Text] [Related]
13. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications].
Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690
[TBL] [Abstract][Full Text] [Related]
14. [Our initial experience with SMANCS in TAE for liver cancer].
Fujita M; Inoue E; Kuroda C; Kasugai H; Sasaki Y; Nakano H; Imaoka S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697
[TBL] [Abstract][Full Text] [Related]
15. [Efficiency of segmental SMANCS/Lip-TAE for hepatocellular carcinoma--comparative studies in the efficacy of segmental SMANCS/Lip-TAI].
Matoba M; Mitsuya T; Ichiyanagi K; Morita M; Kidani E; Ibe N; Tatsumi Y; Tamamura H; Nakagawa T; Okimura T; Yamamoto I
Gan To Kagaku Ryoho; 1997 Jan; 24(1):37-42. PubMed ID: 9020943
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hepatocellular carcinoma by segmental SMANCS Lipiodol-TAE].
Hayashi T; Uchida H; Matsuo N; Sakaguchi H; Anai H; Tanaka T; Yamamoto T; Ooue S; Yoshioka T; Makutani S; Oishi H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():116-24. PubMed ID: 9512699
[TBL] [Abstract][Full Text] [Related]
17. [SMANCS-TAE combined with PEI in the treatment for hepatocellular carcinoma].
Numata K; Tanaka K; Kiba T; Saito S; Morita K; Kitamura T; Kondo M; Morimoto M; Shirato K; Hori A; Shimamura T; Isozaki T; Arata S; Okazaki H; Fujii T; Sekihara H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():141-5. PubMed ID: 9512702
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of therapeutic effects of SMANCS (+TAE) and Non-SMANCS/LpTAE].
Nabeshima M; Ochi J; Hikita H; Nishikawa H; Ohara T; Torii A; Fujita S; Takeda J; Miura K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():99-104. PubMed ID: 9512696
[TBL] [Abstract][Full Text] [Related]
19. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
[TBL] [Abstract][Full Text] [Related]
20. [Advantages and disadvantages of SMANCS-Lipiodol intrahepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma].
Suzuki M; Fukuhara K; Unno M; Endoh K; Takeuchi H; Kodama H; Oikawa M; Matsuno S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():39-45. PubMed ID: 9512686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
